SEC Form 4 · accession 0000950138-16-001185
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kathy A Schaefer
Officer — VP, Finance & Corp Controller
Period of report
Jul 1, 2016
Accepted (ET)
Jul 6, 2016 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jul 1, 2016 | F | 275 | $61.84 | D | 10,359 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 268 shares acquired between January 7, 2016 and June 6, 2016 under the Mallinckrodt employee stock purchase plan.